Associate Director, Continuous Improvement Initiatives & Process Management (1/2)

CSL's R&D organization is accelerating innovation to deliver greater impact for patients. With a project-led structure and a focus on collaboration, we're building a future-ready team that thrives in dynamic biotech ecosystems. Joining CSL now means being part of an agile team committed to developing therapies that make a meaningful difference worldwide. Support the implementation, evaluation and continual processes improvements initiatives for R&D Key Responsibilities Support implementation of value add, cost saving, productivity initiatives to maximize R&D investment: where appropriate, provide project leadership for such initiatives (matrix teams and FSP as needed) Lead continuous improvement initiatives for Cross-R&D business issues resolution team, Business Partners Network to deliver the strategic initiatives selected by RDLT (matrix organization and FSP) Secondary support for cross R&D business related issues Oversee audit implementation, analysis and follow-up Coordinate BAR/AAR COE (Before and After-Action Reviews) R&D new training liaison Skills and Experience Required 10+ years in R&D operations, business support Strong coordination skills Experience working in cross-functional R&D teams Experience in data driven process improvement Established and credible experience in project management Working knowledge in drug research, development and manufacturing processes of pharmaceuticals Qualifications and Education Required Bachelors in science, operations, or business-related field Our Benefits We encourage you to make your well-being a priority. It's important and so are you. Learn more about at CSL. About CSL Behring is a global biotherapeutics leader driven by our promise to save lives. Focused on serving patients' needs by using the latest technologies, we discover, develop and deliver innovative therapies for people living with conditions in the immunology, hematology, cardiovascular and metabolic, respiratory, and transplant therapeutic areas. We use three strategic scientific platforms of plasma fractionation, recombinant protein technology, and cell and gene therapy to support continued innovation and continually refine ways in which products can address unmet medical needs and help patients lead full lives.CSL Behring operates one of the world's largest plasma collection networks, . Our parent company headquartered in Melbourne, Australia, employs 32,000 people, and delivers its lifesaving therapies to people in more than 100 countries. We want CSL to reflect the world around us At CSL, Inclusion and Belonging is at the core of our mission and who we are. It fuels our innovation day in and day out. By celebrating our differences and creating a culture of curiosity and empathy, we are able to better understand and connect with our patients and donors, foster strong relationships with our stakeholders, and sustain a diverse workforce that will move our company and industry into the future. Learn more Do work that matters at CSL Behring!